Trade Bolt Biotherapeutics, Inc. - BOLT CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0102 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.5002 |
Open | 0.4964 |
1-Year Change | -49.7% |
Day's Range | 0.4792 - 0.4984 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 20, 2024 | 0.4913 | -0.0051 | -1.03% | 0.4964 | 0.5029 | 0.4784 |
Dec 19, 2024 | 0.5002 | -0.0008 | -0.16% | 0.5010 | 0.5084 | 0.4784 |
Dec 18, 2024 | 0.5034 | -0.0150 | -2.89% | 0.5184 | 0.5230 | 0.5013 |
Dec 17, 2024 | 0.5139 | -0.0025 | -0.48% | 0.5164 | 0.5229 | 0.5084 |
Dec 16, 2024 | 0.5084 | -0.0100 | -1.93% | 0.5184 | 0.5185 | 0.5005 |
Dec 13, 2024 | 0.5169 | -0.0115 | -2.18% | 0.5284 | 0.5285 | 0.5084 |
Dec 12, 2024 | 0.5254 | -0.0330 | -5.91% | 0.5584 | 0.5714 | 0.5195 |
Dec 11, 2024 | 0.5549 | -0.0147 | -2.58% | 0.5696 | 0.5696 | 0.5494 |
Dec 10, 2024 | 0.5591 | 0.0000 | 0.00% | 0.5591 | 0.5700 | 0.5584 |
Dec 9, 2024 | 0.5673 | -0.0210 | -3.57% | 0.5883 | 0.5985 | 0.5591 |
Dec 6, 2024 | 0.5785 | 0.0001 | 0.02% | 0.5784 | 0.5854 | 0.5779 |
Dec 5, 2024 | 0.5614 | -0.0170 | -2.94% | 0.5784 | 0.5884 | 0.5484 |
Dec 4, 2024 | 0.5784 | -0.0395 | -6.39% | 0.6179 | 0.6179 | 0.5672 |
Dec 3, 2024 | 0.6235 | 0.0005 | 0.08% | 0.6230 | 0.6271 | 0.6149 |
Dec 2, 2024 | 0.6235 | 0.0050 | 0.81% | 0.6185 | 0.6435 | 0.6162 |
Nov 29, 2024 | 0.6354 | 0.0270 | 4.44% | 0.6084 | 0.6355 | 0.6035 |
Nov 27, 2024 | 0.6117 | 0.0061 | 1.01% | 0.6056 | 0.6272 | 0.5984 |
Nov 26, 2024 | 0.6230 | 0.0546 | 9.61% | 0.5684 | 0.6385 | 0.5684 |
Nov 25, 2024 | 0.5984 | 0.0420 | 7.55% | 0.5564 | 0.6052 | 0.5564 |
Nov 22, 2024 | 0.5768 | 0.0184 | 3.30% | 0.5584 | 0.5785 | 0.5502 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Bolt Biotherapeutics, Inc. Company profile
About Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc is a clinical-stage immuno-oncology company. The Company is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Its Immune-Stimulating Antibody Conjugate (ISAC) approach uses immunostimulants to engage and activate myeloid cells, including macrophages and dendritic cells, that kill tumor cells via phagocytosis and expose tumor neoantigens to the adaptive immune system. The Company’s product candidate BDC-1001 is a human epidermal growth factor receptor 2 (HER2) Boltbody ISAC comprised of a HER2-targeting biosimilar, of trastuzumab conjugated to one of its TLR7/8 agonists, for the treatment of patients with HER2-expressing solid tumors, including those with HER2-low tumors. Its Toll-like receptors (TLRs) activate myeloid cells and enable the presentation of tumor-associated neoantigens to cytotoxic T cells.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Bolt Biotherapeutics Inc revenues increased from $231K to $752K. Net loss increased from $29.7M to $71.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and d increase of 99% to $49.8M (expense), Fair Value Adjustments on Other Assets decrease from $2.4M (income) to $6.1M (expense).
Industry: | Bio Therapeutic Drugs |
900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com